Super General Inc

Astex Pharmaceuticals, a member of the Otsuka Group, is dedicated to advancing oncology through innovative research and development. The company focuses on discovering and developing targeted therapeutics for cancer treatment, with a robust clinical pipeline that includes various inhibitors and antagonists aimed at specific oncogenic pathways.

Committed to corporate social responsibility, Astex emphasizes sustainability and collaboration within the healthcare community. Their proprietary products and programs, such as Tolinapant and ASTX660, aim to address unmet medical needs in oncology and beyond.

Generated from the website